Oncología médica
Especialidad
Complejo Hospitalario Universitario de Albacete
Albacete, EspañaPublikationen in Zusammenarbeit mit Forschern von Complejo Hospitalario Universitario de Albacete (9)
2022
-
Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis
European Journal of Internal Medicine, Vol. 105, pp. 30-37
2021
-
Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer
Urologic Oncology: Seminars and Original Investigations, Vol. 39, Núm. 2, pp. 135.e17-135.e23
-
The pseudokinase TRIB3 negatively regulates the HER2 receptor pathway and is a biomarker of good prognosis in luminal breast cancer
Cancers, Vol. 13, Núm. 21
2019
-
Treatment and outcome of patients with stage is testicular cancer: A retrospective study from the Spanish germ cell cancer group
Journal of Urology, Vol. 202, Núm. 4, pp. 742-747
2018
-
First analysis of patients (p) with stage IV non-small cell lung cancer (NSCLC) of the thoracic tumor registry (RTT) of the Spanish Lung Cancer Group (SLCG)
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii535-viii536
-
Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy
Clinical and Translational Oncology, Vol. 20, Núm. 12, pp. 1548-1556
2017
2013
-
Dolor como factor predictor de depresión en el paciente oncológico: estudio de casos y controles. Estudio D-PRESS
Revista de la Sociedad Espanola del Dolor, Vol. 20, Núm. 3, pp. 113-121
2003
-
Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma
Annals of Oncology, Vol. 14, Núm. 6, pp. 867-872